Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The rotavirus vaccine

P A Offit1

  • 1Section of Infectious Diseases, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, USA. offit@email.chop.edu

Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|February 9, 1999
PubMed
Summary

A new rotavirus vaccine offers significant protection against severe gastroenteritis in infants. This oral vaccine, combining animal and human strains, is expected to reduce rotavirus-related deaths and hospitalizations globally.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunologic methods and correlates of protection.

Methods in molecular medicine·2011
Same author

Specific attachment of aqueous-based microcapsules to macrophages, B cells, and dendritic cells in vitro.

Journal of microencapsulation·2002
Same author

How vaccine safety is monitored before and after licensure.

Pediatric annals·2001
Same author

Correlates of protection against rotavirus infection and disease.

Novartis Foundation symposium·2001
Same author

B2 but not B1 cells can contribute to CD4+ T-cell-mediated clearance of rotavirus in SCID mice.

Journal of virology·2001
Same author

Hypertrophy, hyperplasia, and infectious virus in gut-associated lymphoid tissue of mice after oral inoculation with simian-human or bovine-human reassortant rotaviruses.

The Journal of infectious diseases·2001

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Background:

  • Rotavirus gastroenteritis poses a significant global health burden, causing widespread morbidity and mortality, particularly in infants.
  • Understanding the complex biology, immunology, and virology of rotavirus is crucial for developing effective interventions.

Purpose of the Study:

  • To review the fundamental aspects of rotavirus, including its biology, immunology, and virology.
  • To discuss the development and potential impact of rotavirus vaccines, utilizing both human and animal rotavirus strains.

Main Methods:

  • A comprehensive literature review was conducted.
  • Author's insights and speculations on infant vaccination against rotavirus disease were incorporated.

Main Results:

  • The U.S. Food and Drug Administration approved a novel rotavirus vaccine in August 1998.
  • This vaccine, a combination of a simian rotavirus strain (RRV) and multiple human strains, targets various rotavirus serotypes.
  • Recommendations suggest a three-dose oral administration for infants at 2, 4, and 6 months of age.

Conclusions:

  • The rotavirus vaccine, when administered as recommended, is anticipated to substantially decrease rotavirus-induced deaths, hospitalizations, and medical visits in children.
  • This advancement in vaccinology holds promise for mitigating the impact of rotavirus disease worldwide.

Related Experiment Videos